# Ohio Valley Banc Corp: financial statements, quarterly

OVBC · Nasdaq · CIK 894671 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ovbc.md) · [Financials](/companies/ovbc/financials.md) · [Filings](/companies/ovbc/filings.md) · [Insiders](/companies/ovbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ovbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [4,556](/filings/0000894671-23-000038.md) | [5,807 d](/filings/0001140361-24-013512.md) | [6,494](/filings/0000894671-24-000015.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [426](/filings/0000894671-24-000026.md) | [682 d](/filings/0001140361-25-008828.md) | [601](/filings/0000894671-25-000026.md) | [648](/filings/0000894671-25-000036.md) | [576](/filings/0000894671-25-000070.md) | [552 d](/filings/0001140361-26-009342.md) | [1,146](/filings/0000894671-26-000039.md) | [976](/filings/0000894671-26-000052.md) | [714](/filings/0000894671-25-000070.md) | [1,015 d](/filings/0001140361-26-009342.md) | [956](/filings/0000894671-26-000039.md) | [657](/filings/0000894671-26-000052.md) |
| Net income | $k | [2,251](/filings/0000894671-24-000026.md) | [3,223 d](/filings/0001140361-25-008828.md) | [2,793](/filings/0000894671-25-000026.md) | [2,972](/filings/0000894671-25-000036.md) | [2,719](/filings/0000894671-25-000070.md) | [2,515 d](/filings/0001140361-26-009342.md) | [4,406](/filings/0000894671-26-000039.md) | [4,210](/filings/0000894671-26-000052.md) | [3,030](/filings/0000894671-25-000070.md) | [3,955 d](/filings/0001140361-26-009342.md) | [4,297](/filings/0000894671-26-000039.md) | [2,927](/filings/0000894671-26-000052.md) |
| Basic EPS | $ per share | [0.47](/filings/0000894671-24-000026.md) | not reported | [0.58](/filings/0000894671-25-000026.md) | [0.63](/filings/0000894671-25-000036.md) | [0.58](/filings/0000894671-25-000070.md) | not reported | [0.94](/filings/0000894671-26-000039.md) | [0.89](/filings/0000894671-26-000052.md) | [0.64](/filings/0000894671-25-000070.md) | not reported | [0.91](/filings/0000894671-26-000039.md) | [0.62](/filings/0000894671-26-000052.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [91.2](/filings/0000894671-23-000038.md) | [128](/filings/0001140361-25-008828.md) | [129](/filings/0000894671-24-000015.md) | [108](/filings/0000894671-24-000020.md) | [82.2](/filings/0000894671-24-000026.md) | [83.1](/filings/0001140361-26-009342.md) | [121](/filings/0000894671-25-000026.md) | [54.6](/filings/0000894671-25-000036.md) | [89.3](/filings/0000894671-25-000070.md) | [45.9](/filings/0000894671-26-000052.md) | [125](/filings/0000894671-26-000039.md) | [78.1](/filings/0000894671-26-000052.md) |
| Total assets | $m | [1,314](/filings/0000894671-24-000026.md) | [1,352](/filings/0001140361-25-008828.md) | [1,373](/filings/0000894671-24-000015.md) | [1,403](/filings/0000894671-24-000020.md) | [1,494](/filings/0000894671-24-000026.md) | [1,503](/filings/0001140361-26-009342.md) | [1,513](/filings/0000894671-25-000026.md) | [1,510](/filings/0000894671-25-000036.md) | [1,570](/filings/0000894671-25-000070.md) | [1,583](/filings/0000894671-26-000052.md) | [1,678](/filings/0000894671-26-000039.md) | [1,661](/filings/0000894671-26-000052.md) |
| Total liabilities | $m | [1,177](/filings/0000894671-23-000038.md) | [1,208](/filings/0001140361-25-008828.md) | [1,227](/filings/0000894671-24-000015.md) | [1,258](/filings/0000894671-24-000020.md) | [1,342](/filings/0000894671-24-000026.md) | [1,353](/filings/0001140361-26-009342.md) | [1,357](/filings/0000894671-25-000026.md) | [1,350](/filings/0000894671-25-000036.md) | [1,406](/filings/0000894671-25-000070.md) | [1,412](/filings/0000894671-26-000052.md) | [1,506](/filings/0000894671-26-000039.md) | [1,488](/filings/0000894671-26-000052.md) |
| Shareholders' equity | $m | [137](/filings/0000894671-24-000026.md) | [144](/filings/0001140361-26-009342.md) | [146](/filings/0000894671-25-000036.md) | [146](/filings/0000894671-25-000070.md) | [152](/filings/0000894671-25-000070.md) | [150](/filings/0000894671-26-000052.md) | [156](/filings/0000894671-26-000052.md) | [161](/filings/0000894671-26-000052.md) | [164](/filings/0000894671-25-000070.md) | [170](/filings/0000894671-26-000052.md) | [171](/filings/0000894671-26-000052.md) | [173](/filings/0000894671-26-000052.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [5,971 d](/filings/0000894671-24-000026.md) | [6,600 d](/filings/0001140361-25-008828.md) | [928](/filings/0000894671-25-000026.md) | [4,180 d](/filings/0000894671-25-000036.md) | [5,599 d](/filings/0000894671-25-000070.md) | [2,390 d](/filings/0001140361-26-009342.md) | [496](/filings/0000894671-26-000039.md) | [4,478 d](/filings/0000894671-26-000052.md) | [5,313 d](/filings/0000894671-25-000070.md) | [7,798 d](/filings/0001140361-26-009342.md) | [7,190](/filings/0000894671-26-000039.md) | [2,641 d](/filings/0000894671-26-000052.md) |
| Capital expenditure | $k | [562 d](/filings/0000894671-24-000026.md) | [705 d](/filings/0001140361-25-008828.md) | [694](/filings/0000894671-25-000026.md) | [323 d](/filings/0000894671-25-000036.md) | [183 d](/filings/0000894671-25-000070.md) | [233 d](/filings/0001140361-26-009342.md) | [358](/filings/0000894671-26-000039.md) | [109 d](/filings/0000894671-26-000052.md) | [341 d](/filings/0000894671-25-000070.md) | [229 d](/filings/0001140361-26-009342.md) | [387](/filings/0000894671-26-000039.md) | [2,271 d](/filings/0000894671-26-000052.md) |
| Dividends paid | $k | [1,051 d](/filings/0000894671-24-000026.md) | [1,051 d](/filings/0001140361-25-008828.md) | [1,050](/filings/0000894671-25-000026.md) | [1,055 d](/filings/0000894671-25-000036.md) | [1,036 d](/filings/0000894671-25-000070.md) | [1,036 d](/filings/0001140361-26-009342.md) | [1,037](/filings/0000894671-26-000039.md) | [1,084 d](/filings/0000894671-26-000052.md) | [1,083 d](/filings/0000894671-25-000070.md) | [1,083 d](/filings/0001140361-26-009342.md) | [1,084](/filings/0000894671-26-000039.md) | [1,178 d](/filings/0000894671-26-000052.md) |
| Share repurchases | $k | [82.0 d](/filings/0000894671-24-000026.md) | [0.0 d](/filings/0001140361-25-008828.md) | not reported | not reported | [0.0 d](/filings/0000894671-25-000070.md) | [14.0 d](/filings/0001140361-26-009342.md) | not reported | not reported | [0.0 d](/filings/0000894671-25-000070.md) | [0.0 d](/filings/0001140361-26-009342.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2016 (2016-03-31) | Q1 FY2017 (2017-03-31) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | units of shares | [0.0](/filings/0000894671-17-000024.md) | [0.0](/filings/0000894671-17-000024.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,711,001 at 2026-08-12, from the cover of the [10-Q filed 2026-08-13](/filings/0000894671-26-000052.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.